Skip to content
ChinaCSR.com logo

Corporate Social Responsibility & Sustainability in China

Corporate Social Responsibility in China

Tong Ren Tang Once Again Put On Blacklist

January 22, 2008
-
Health

Henan Provincial Food & Drug Administration has listed over 49 kinds of drugs involved in illegal advertising to the local departments for industry and commerce for punishment and the well-known Chinese medicine brand Tong Ren Tang has been included in the list.

HPFDA said that four types of medicines made by Beijing Tong Ren Tang's pharmaceutical factories, including the capsule for quenching thirst and lowering sugar levels, Dou Liang Wan, Xin Fang Rhinitis Capsule and Prostate Shule Capsule were all involved in publishing illegal advertisements.

In addition, Fufang Shouwu Dihuang Wan made by Jilin Xiuzheng Pharmaceutical Group Co., Ltd.; San Tong Shu Pian made by Yunnan Panlong Yunhai Pharmaceutical Co., Ltd; and Fufang Qinghao Pen Wu Ji by Kunming Pharmaceutical Co., Ltd were also published on the blacklist.

According to Chinese media, in the past six years, a total of 37 kinds of Tong Ren Tang medicines were suspected of releasing illegal advertisements by exaggerating medicines' functions and even making fake approval serial numbers.

Readers also read this:

XCMG Machinery Releases ESG Report

August 14, 2024

Norwegian Agri CEO Makes Green Visit To China

June 1, 2024

Sino-French Dairy Cooperation Takes Flight

May 15, 2024

China Construction Bank Signs ESG Platform Deal In Singapore

April 30, 2024

Inaugural One Earth Summit Concludes In Hong Kong

March 28, 2024

United Nations Global Compact Welcomes Latest Chinese Company

February 8, 2024
  • About Us
  • Contact Us
  • Corrections and Disclosure Policy
  • Privacy Policy
  • Terms & Conditions
  • 中文
Menu
  • About Us
  • Contact Us
  • Corrections and Disclosure Policy
  • Privacy Policy
  • Terms & Conditions
  • 中文

Copyright 2026 © ChinaCSR.com. All Rights Reserved. A service of Asia Media Network. If you would like to syndicate these articles and posts, please utilize the RSS feed for this online publication, which provides a brief summary of each post with a link back to the original article. Posting of any other part of the articles or posts on this website for commercial purposes created by ChinaCSR.com, in whole or in part, is expressly prohibited without express written permission from ChinaCSR.com. Individual news stories curated from other sources are copyright their respective sources.

Asia Media Network